Desmoplastic Cutaneous Squamous Cell Carcinoma Is an Aggressive and Potentially Fatal Skin Cancer: A Systematic Review.

IF 1.1 4区 医学 Q3 DERMATOLOGY
Journal of Cutaneous Pathology Pub Date : 2026-06-01 Epub Date: 2026-03-15 DOI:10.1111/cup.70079
Andrew Dettrick, Haris Mohammed, Thomas Hardman, Nicole Buddle, Ryan Livingston, Duncan Lambie, Rebecca Donkin
{"title":"Desmoplastic Cutaneous Squamous Cell Carcinoma Is an Aggressive and Potentially Fatal Skin Cancer: A Systematic Review.","authors":"Andrew Dettrick, Haris Mohammed, Thomas Hardman, Nicole Buddle, Ryan Livingston, Duncan Lambie, Rebecca Donkin","doi":"10.1111/cup.70079","DOIUrl":null,"url":null,"abstract":"<p><p>The incidence and mortality of cutaneous squamous cell carcinoma (cSCC) are increasing. Desmoplastic cSCC (dcSCC) is an uncommon yet highly aggressive variant which has received relatively little attention in the literature. No systematic reviews of dcSCC are currently available. This paper aims to summarize the current understanding of the behavior of dcSCC by conducting a systematic review of published series with particular focus on outcomes. A comprehensive search was conducted for original series in English. Six studies reporting a total of 286 dcSCC were included in the final analysis. Most series were single site and retrospective. Pooled estimates demonstrated local recurrence rate 30% (95% CI: 24%-36%, p = 0.765), nodal metastasis 17% (95% CI: 12%-22%, p = 0.158), distant metastasis 5% (95% CI: 2%-9%, p = 0.574) and disease-specific death 12% (95% CI: 3%-36%, p = 0.047), outcomes which are considerably worse than non-dcSCC. The findings confirm the aggressive nature of dcSCC and suggest early aggressive treatment is warranted. However, given the limitations of existing studies, there is a need for large, prospective, multicentre studies to better define prognostic factors and optimize management strategies.</p>","PeriodicalId":15407,"journal":{"name":"Journal of Cutaneous Pathology","volume":" ","pages":"551-561"},"PeriodicalIF":1.1000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13136062/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cutaneous Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/cup.70079","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The incidence and mortality of cutaneous squamous cell carcinoma (cSCC) are increasing. Desmoplastic cSCC (dcSCC) is an uncommon yet highly aggressive variant which has received relatively little attention in the literature. No systematic reviews of dcSCC are currently available. This paper aims to summarize the current understanding of the behavior of dcSCC by conducting a systematic review of published series with particular focus on outcomes. A comprehensive search was conducted for original series in English. Six studies reporting a total of 286 dcSCC were included in the final analysis. Most series were single site and retrospective. Pooled estimates demonstrated local recurrence rate 30% (95% CI: 24%-36%, p = 0.765), nodal metastasis 17% (95% CI: 12%-22%, p = 0.158), distant metastasis 5% (95% CI: 2%-9%, p = 0.574) and disease-specific death 12% (95% CI: 3%-36%, p = 0.047), outcomes which are considerably worse than non-dcSCC. The findings confirm the aggressive nature of dcSCC and suggest early aggressive treatment is warranted. However, given the limitations of existing studies, there is a need for large, prospective, multicentre studies to better define prognostic factors and optimize management strategies.

促结缔组织增生皮肤鳞状细胞癌是一种侵袭性和潜在致命的皮肤癌:系统综述。
皮肤鳞状细胞癌(cSCC)的发病率和死亡率呈上升趋势。结缔组织增生性cSCC (dcSCC)是一种罕见但具有高度侵袭性的变异,在文献中受到的关注相对较少。目前尚无关于dcSCC的系统综述。本文旨在通过对已发表的系列文章进行系统回顾,特别关注结果,总结目前对dcSCC行为的理解。对英文原创剧集进行了全面的检索。6项研究共报道286例dcSCC被纳入最终分析。大多数系列是单地点和回顾性的。合并估计显示,局部复发率为30% (95% CI: 24%-36%, p = 0.765),淋巴结转移率为17% (95% CI: 12%-22%, p = 0.158),远处转移率为5% (95% CI: 2%-9%, p = 0.574),疾病特异性死亡率为12% (95% CI: 3%-36%, p = 0.047),这些结果明显差于非dcscc。研究结果证实了dcSCC的侵袭性,并建议早期积极治疗是必要的。然而,鉴于现有研究的局限性,需要进行大型、前瞻性、多中心的研究,以更好地确定预后因素并优化管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
5.90%
发文量
174
审稿时长
3-8 weeks
期刊介绍: Journal of Cutaneous Pathology publishes manuscripts broadly relevant to diseases of the skin and mucosae, with the aims of advancing scientific knowledge regarding dermatopathology and enhancing the communication between clinical practitioners and research scientists. Original scientific manuscripts on diagnostic and experimental cutaneous pathology are especially desirable. Timely, pertinent review articles also will be given high priority. Manuscripts based on light, fluorescence, and electron microscopy, histochemistry, immunology, molecular biology, and genetics, as well as allied sciences, are all welcome, provided their principal focus is on cutaneous pathology. Publication time will be kept as short as possible, ensuring that articles will be quickly available to all interested in this speciality.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书